Maennling, A.E.; Tur, M.K.; Niebert, M.; Klockenbring, T.; Zeppernick, F.; Gattenlöhner, S.; Meinhold-Heerlein, I.; Hussain, A.F.
Molecular Targeting Therapy against EGFR Family in Breast Cancer: Progress and Future Potentials. Cancers 2019, 11, 1826.
https://doi.org/10.3390/cancers11121826
AMA Style
Maennling AE, Tur MK, Niebert M, Klockenbring T, Zeppernick F, Gattenlöhner S, Meinhold-Heerlein I, Hussain AF.
Molecular Targeting Therapy against EGFR Family in Breast Cancer: Progress and Future Potentials. Cancers. 2019; 11(12):1826.
https://doi.org/10.3390/cancers11121826
Chicago/Turabian Style
Maennling, Amaia Eleonora, Mehmet Kemal Tur, Marcus Niebert, Torsten Klockenbring, Felix Zeppernick, Stefan Gattenlöhner, Ivo Meinhold-Heerlein, and Ahmad Fawzi Hussain.
2019. "Molecular Targeting Therapy against EGFR Family in Breast Cancer: Progress and Future Potentials" Cancers 11, no. 12: 1826.
https://doi.org/10.3390/cancers11121826
APA Style
Maennling, A. E., Tur, M. K., Niebert, M., Klockenbring, T., Zeppernick, F., Gattenlöhner, S., Meinhold-Heerlein, I., & Hussain, A. F.
(2019). Molecular Targeting Therapy against EGFR Family in Breast Cancer: Progress and Future Potentials. Cancers, 11(12), 1826.
https://doi.org/10.3390/cancers11121826